Document:

Exhibit

Exhibit 10.22
WITHOUT PREJUDICE / SUBJECT TO CONTRACT
Compromise Agreement
	
			
	THIS AGREEMENT is made on
	05
	Oct 2019

	 
	 
	 

	BETWEEN
	 
	 

		
	(1)
	JAZZ PHARMACEUTICALS IRELAND LIMITED a company incorporated under the laws of Ireland having its registered office at Fifth Floor, Waterloo Exchange, Waterloo Road, Dublin 4 ( the “Company”);

AND
		
	(2)
	PAUL TREACY of Ireland (the “Employee”). 

(Each a “Party” and collectively the “Parties”) 
WHEREAS:
		
	A.
	The Employee is presently employed by the Company on the terms and the conditions set out in a contract of employment dated 10 June 2014, executed by the Employee on 23 June 2014, and amended by letter dated 8 December 2014 (the “Employment Contract”).

		
	B.
	It is agreed that the three-month notice of termination of the Employee’s employment pursuant to clause 15 of the Employment Contract shall officially begin as of 1 October 2019 (the “Notice Effective Date”).

		
	C.
	The Company is entering into this Agreement for itself and on behalf of each of its Associated Undertakings.

IT IS HEREBY AGREED as follows:
		
	1.
	Termination of employment; Transition Assistance.

		
	1.1
	The Employee’s employment with the Company shall terminate on 31 December 2019 (the “Termination Date”). Prior to the Notice Effective Date, the Employee will reasonably cooperate with the Company and provide full transition assistance with respect to his role, duties and projects, including, but not limited to, working closely with Daniel Swisher on preparing and implementing a mutually acceptable communication plan regarding his departure (including internal and external communications), and the transition plan for his responsibilities and relationships.

		
	1.2
	Save as set out in this Agreement, the Employee’s entitlement to salary and all other benefits associated with his employment by the Company shall continue until the Termination Date when they shall cease.

		
	1.3
	By reason of the termination of his employment, the Employee is entitled to receive the following payments:

		
	1.3.1
	salary and contractual benefits up to and including the Termination Date; and 

		
	1.3.2
	payment in lieu of outstanding annual leave accrued by the Employee, but not taken at the Termination Date.

1

		
	1.4
	The payments specified in clause 1.3 shall be paid in the ordinary course via Company payroll and shall be subject to such income tax, PRSI and USC and other deductions as the Company is required (or permitted) to deduct from the gross amount and remit to the Irish Revenue Commissioners and/or any other tax or, governmental or, fiscal authority (“Revenue”) under the relevant tax and social welfare (or equivalent) legislation.

		
	2.
	Garden Leave

		
	2.1
	Between the Notice Effective Date and the Termination Date, the Employee shall be on paid garden leave. During the garden leave period, the Company shall not be obliged to provide the Employee with any work or assign to him any powers, duties or functions (and shall be entitled to appoint the Employee’s successor). Save as agreed or requested by the Company, during the garden leave period the Employee: shall be removed from his position and not undertake any job duties; shall not enter any premises of the Company or any Associated Undertaking; and shall not engage in any contact (whether or not initiated by him), other than social contact, with any customer, client, supplier, consultant or agent of the Company or any Associated Undertaking.

		
	2.2
	For the avoidance of doubt, during the garden leave period the Employee shall continue to be bound by the duties of fidelity and good faith and shall comply with any and all relevant obligations under the Employment Contract or implied by common law (including but not limited to the duties of confidentiality and trust and confidence).

		
	2.3
	During the garden leave period, the Company may require the Employee to undertake at his home or at the premises of the Company or any Associated Undertaking or at such place reasonably nominated by the Company such reasonable duties as the Company may at its discretion assign to him and to provide any reasonable assistance requested by the Company or any Associated Undertaking. In particular, the Employee shall be required to provide full transition assistance to the Company including (but not limited to) assistance with regard to a mutually acceptable communication plan regarding his departure, and the transition of his responsibilities and relationships. The Employee shall hold himself available and remain contactable during normal business hours (other than agreed holidays or authorised sickness) to perform any such duties or provide any such assistance and shall ensure that the Company has up to date contact details for him.

		
	3.
	Consideration, settlement, release and discharge

		
	3.1
	As compensation for the Employee’s loss of employment, and subject to compliance by the Employee with his obligations under this Agreement, including providing the transition assistance discussed in clause 1.1 and signing and returning the Supplemental Waiver of Claims referred to in clause 9 (below), the Company shall make an ex gratia payment (the “Termination Payment”) to the Employee by no later than the Payment Date (defined below) consisting of the following amounts: (a) 2019 bonus in the amount of €180,000; (b) 2020 bonus in the amount of €180,000; (c) twenty-four (24) months of basic salary in the amount of €800,000; and (d) an amount equivalent to twenty-four (24) months of the Employee’s regular monthly employee benefits in effect as of the Termination Date.

		
	3.2
	The Termination Payment shall be in full and final settlement, release and discharge of any and all actions or causes of actions, claims, complaints, contracts, liabilities and agreements (if any) as the Employee has or may have against the Company and/or any Associated Undertaking, and its or their employees, officers, shareholders and agents, whether arising under Statute, common law, contract, tort (including claims for personal injuries), equity or otherwise arising out of his employment and/or the termination of such employment.

		
	3.3
	For the purposes of this Agreement, the expression ‘Statute’ shall include, but not be limited to the following:

		
	•
	the Redundancy Payments Acts 1967- 2014;

2

		
	•
	the Terms of Employment (Information) Acts 1994 - 2014;

		
	•
	the Minimum Notice and Terms of Employment Acts 1973 - 2005;

		
	•
	the Protection of Employment Act 1977 - 2014;

		
	•
	the Protection of Employment (Exceptional Collective Redundancies and Related Matters) Act 2007;

		
	•
	the Organisation of Working Time Act 1997;

		
	•
	the Payment of Wages Act 1991;

		
	•
	the Unfair Dismissals Acts 1977 - 2015;

		
	•
	the Protected Disclosures Act 2014;

		
	•
	the Employment Equality Acts 1998 - 2015;

		
	•
	the European Communities (Protection of Employees on Transfer of Undertakings) Regulations 2003;

		
	•
	the Maternity Protection Acts 1994 and 2004;

		
	•
	the Adoptive Leave Acts 1995 and 2005;

		
	•
	the Parental Leave Acts 1998 and 2006;

		
	•
	the Paternity Leave and Benefit Act 2016;

		
	•
	the National Minimum Wage Acts 2000 and 2015;

		
	•
	the Carer’s Leave Act 2001 (as amended);

		
	•
	the Protection of Employees (Part-Time Work) Act 2001;

		
	•
	the Protection of Employees (Fixed-Term Work) Act 2003;

		
	•
	the Industrial Relations Acts, 1946 - 2015;

		
	•
	the Data Protection Acts 1988 - 2018;

		
	•
	the Workplace Relations Act 2015;

		
	•
	the Employment (Miscellaneous Provisions) Act 2018; and

		
	•
	the Safety Health and Welfare at Work Act 2005 - 2014.

		
	3.4
	For the purposes of clause 3.1, the “Payment Date” shall mean the date which is 30 days after the date on which the Company receives from the Employee a duly executed copy of the Supplemental Waiver of Claims (provided that the Employee signs and returns this Agreement by no later than 4 October 2019).

		
	3.5
	The Employee acknowledges that the payment to him of the Termination Payment is made without any admission of any liability or breach of statute or law by the Company or of any duty or obligation owed to him by the Company.

3

		
	3.6
	Subject to the Employee’s signature of the Form of letter attached at Appendix 1 in a form satisfactory to the Company, the Termination Payment will be made in the most tax efficient manner permitted by law provided that this does not result in any additional cost or liability whatsoever to the Company and, subject thereto, the Termination Payment shall be subject to such income tax, PRSI, USC and other deductions as the Company is required to deduct from the gross amount and remit to Revenue under the relevant tax and social welfare legislation.

		
	3.7
	The Employee hereby agrees to indemnify and hold harmless the Company and any Associated Undertaking in full (on a continuing basis) against any tax liabilities, charges, levies, duties, social security liabilities, withholdings, other fiscal impositions and other similar deductions of any kind whatsoever, including any interest, charges, surcharges, fines and penalties thereon or claims made by Revenue arising from or in connection with the payment of the Termination Payment and any other payments contemplated under this Agreement, which may arise subsequent to the date hereof.

		
	4.
	Continuing obligations

		
	4.1
	The Employee shall continue to be bound by any of the provisions of the Employment Contract which are expressed to take effect on or to continue after the termination of his employment including, but not limited to, clauses 23, 24 and 25 thereof.

		
	4.2
	The Employee hereby covenants and agrees that he will not, from the Termination Date, hold himself out or expressly or impliedly represent to any third party that he has the authority to speak for, represent or in any way bind the Company, or any of its Associated Undertakings.

		
	4.3
	Without prejudice to any obligations owed by him under the Employment Contract, the Employee acknowledges that during the term of his employment, he had access to information which is confidential and/or proprietary to the Company, including but not limited to trade secrets, know-how, information that results from research and development, technical data, information concerning past, existing or prospective customers and/or suppliers and other information of a commercial, financial or technical nature relating in any way whatsoever to the business and affairs of the Company, and its Associated Undertakings (“Confidential Information”). The Employee undertakes and agrees that all Confidential Information shall be and remain at all times the exclusive property of the Company. The Employee further undertakes and agrees that he will not at any time prior to or following the termination of his employment with the Company reveal, publish or disclose Confidential Information to any person, association, future employer or company nor shall he use it for his own benefit or for the benefit of others without prior written consent of a duly authorised officer of the Company.

		
	5.
	Return of property

		
	5.1
	The Employee shall, no later than the Notice Effective Date, deliver up to the Company, all property belonging to the Company in his possession or under his control including but not limited to any Company vehicle and all accessories, Company mobile phone, laptop and any other electronic communication devices, security card or key to the premises, Company credit cards, Company files, personnel records, books, returns, Company information, memoranda, data, correspondence and all documentation prepared or obtained by the Employee in the course of his employment with the Company relating to its business and affairs; and the Employee undertakes not to retain copies of any of the foregoing documents without the prior written consent of the Company. The Employee agrees to provide a warranty to the Company, upon request, as to his compliance with this provision.

		
	5.2
	The Employee shall, no later than the Notice Effective Date, provide to the Company full details of all then current passwords used by the Employee in respect of computer equipment belonging to the Company or any Associated Undertaking and, having forwarded a copy to the Company, irretrievably delete from any computer drives, disks, tapes or other re-usable material and/or from any website and/or email account in the Employee’s possession or under his control (but which do not belong to the Company or any Associated Undertaking) any information belonging or relating to the business of the Company or any Associated Undertaking, their customers, clients or suppliers. 

4

After deleting such material, the Employee shall at the Company’s request warrant in writing that he has complied with this clause.
		
	6.
	No voluntary disclosure

Except as disclosure may be required by law (including corporate filing requirements), the Parties agree that the terms of this Agreement are confidential as between the Parties and that they shall not voluntarily divulge or publish, directly or indirectly, any information whatsoever regarding the substance, terms or existence of this Agreement. Notwithstanding the foregoing, the Parties may disclose this Agreement to their legal and other professional advisors, and the Employee may disclose this Agreement in confidence to his immediate family members.
		
	7.
	No adverse remarks

The Employee shall not at any time make any negative or adverse remarks whatsoever concerning the Company or any Associated Undertaking or any of its or their shareholders, directors, officers, employees or agents or concerning the business, operations, technologies, products, services, marketing strategies, pricing policies, management affairs, financial condition, systems and procedures, controls, books and records, or service provider of the Company or any Associated Undertaking. The following individuals shall be instructed not to make negative or adverse remarks whatsoever concerning the Employee’s employment with the Company: Bruce Cozadd, Chief Executive Officer; Daniel Swisher, President and Chief Operating Officer; Heidi Manna, Chief Human Resources Officer; and the members of the Board of Directors of Jazz Pharmaceuticals plc.
		
	8.
	Independent legal advice

		
	8.1
	The Employee confirms and agrees that he has been advised to and afforded the opportunity of obtaining independent legal advice regarding the contents and effect of this Agreement.

		
	8.2
	The Employee acknowledges that he understands the effect and implications of this Agreement. The Employee confirms that he has signed this Agreement with full understanding that he is releasing and compromising any and all claims that he has or might have against the Company arising from or connected with his employment with the Company and the termination of such employment.

		
	9.
	Supplemental waiver of claims

The Employee acknowledges that the payment of the Termination Payment is conditional upon the Employee signing and returning the Supplemental Waiver of Claims (set out in Schedule A to this Agreement) to Heidi Manna, Chief Human Resources Officer, on or within 7 days from the Termination Date.
		
	10.
	General

		
	10.1
	This Agreement shall be governed by and construed in accordance with the laws of Ireland and the courts of Ireland shall have exclusive jurisdiction to deal with all disputes arising from or touching upon this Agreement.

		
	10.2
	For the purposes of this Agreement, “Associated Undertaking” means any undertaking which from time to time is a subsidiary of the Company or is a holding company of the Company or a subsidiary of any such holding company (“holding company” and “subsidiary” having the meanings set out in section 7 and 8 of the Irish Companies Act 2014). By way of example, but not limitation, Jazz Pharmaceuticals plc is an Associated Undertaking;

		
	10.3
	This Agreement contains the whole agreement between the Parties relating to the matters provided for in this Agreement and supersedes all previous agreements (if any) between the Parties in respect 

5

of such matters and each Party acknowledges that in agreeing to enter into this Agreement they have not relied on any representations or warranties except for those contained in this Agreement.
		
	10.4
	This Agreement, although marked “without prejudice” and “subject to contract” shall, upon signature by both parties, be treated as an open document evidencing an agreement that is and will be binding on the parties.

		
	10.5
	This Agreement may be executed by the parties to this Agreement on separate counterparts, each of which when executed shall constitute the original and all such counterparts together constitute but one and the same instrument.

[Signature page follows.]

6

	
			
	Dated the   5   day of   October     2019.
	 

	 
	 
	 

	 
	 
	 

	SIGNED:
	/s/  Paul Treacy
	 

	Paul Treacy
	 
	 

	 
	 
	 

	DATE:
	05   Oct    2019.
	 

	 
	 
	 

	IN THE 
PRESENCE OF:
Witness
	/s/ Veronique O’Sullivan
	 

	 
	 
	 

	Witness name, 
occupation
and address 
	VERONIQUE O'SULLIVAN
	 

	 
	PUBLIC SERVANT
	 

	 
	15 ARDFIELD MEADOWS
	 

	 
	ARDFIELD, DOUGLAS, CORK.
	 

	 
	 
	 

	 
	 
	 

	SIGNED:
	/s/  Heidi Manna
	 

	For and on behalf of the Company
	 

	 
	 
	 

	DATE:
	9/4/19
	 

7

APPENDIX 1
Confirmation Letter
Mr Paul Treacy
Private & Confidential
Jazz Pharmaceuticals Ireland Limited 
Fifth Floor,
Waterloo Exchange,
Waterloo Road,
Dublin 4
Dear Sirs
I refer to the ex gratia Termination Payment referenced in clause 3.1 of the Compromise Agreement between me and Jazz Pharmaceuticals Ireland Limited (the “Company”), to be paid to me by the Company in connection with the termination of my employment.
The term “Termination Date” has the same meaning as in the Compromise Agreement that I entered into with the Company.
I confirm that I have not made a claim under section 123, section 201 or Schedule 3 of the Taxes Consolidation Act 1997 (as amended) within the period of ten years prior to the Termination Date.
I further confirm that the aggregate amount of all tax free payments made to me in respect of any and all ex-gratia payments received by me during my lifetime, including the tax exempt amount in respect of the proposed ex-gratia payment in clause 3.1 of the Compromise Agreement, does not exceed the limit of €200,000 as set out in section 201(8) of the Taxes Consolidation Act 1997 (as amended).
I am entitled to receive a tax-free lump sum in the future under the Company’s occupational pension plan. The net present value as at the Termination Date of the future tax-free lump sum is approximately €164,491.70
	
				
	Yours sincerely
	 
	Witness Name:
	/s/ VERONIQUE O'SULLIVAN

	 
	 
	Witness Address:
	15 ARDFIELD MEADOWS, CORK

	/s/ Paul Treacy
	 
	Witness Occupation:
	PUBLIC SERVANT

	Paul Treacy
	 
	 
	 

	Date:  14 NOV 2019
	 
	Date:  05 . OCT 2019
	 

SCHEDULE A
Supplemental Waiver of Claims
In further consideration of the terms and conditions of the Compromise Agreement executed by me on 05 October 2019, I accept the terms and conditions of this supplemental waiver of claims (“Waiver”) and waive as a full and final settlement, and satisfaction of any and all claims, actions or causes of action, suits, complaints, contracts or liabilities of whatsoever nature made and/or which may be made by me in Ireland and/or in any other jurisdiction anywhere in the world against the Company and any Associated Undertakings and/or each and all of their respective directors, officers, employees, shareholders and agents in connection with and/or arising out of and/or concerning my employment with the Company and/or the termination of such employment.
Without prejudice to the generality of the foregoing, I hereby acknowledge and agree that the provisions made in the Compromise Agreement constitute a full and final settlement of all claims, actions or causes of action and demands made and/or which may be made by me against the Company, any Associated Undertakings and the other persons referred to above, whether such claims arise at common law, in equity, pursuant to Statute (including but not limited to the Redundancy Payments Acts 1967 - 2014; the Terms of Employment (Information) Acts 1994 -2014; the Minimum Notice and Terms of Employment Acts 1973 - 2005; the Protection of Employment Act 1977-2014; the Protection of Employment (Exceptional Collective Redundancies and Related Matters) Act 2007; the Organisation of Working Time Act 1997; the Payment of Wages Act 1991; the Unfair Dismissals Acts 1977 - 2015; the Protected Disclosures Act 2014; the Employment Equality Acts 1998 - 2015; the European Communities (Protection of Employees on Transfer of Undertakings) Regulations 2003; the Maternity Protection Acts 1994 and 2004; the Adoptive Leave Acts 1995 and 2005; the Parental Leave Acts 1998 and 2006; the Paternity Leave and Benefit Act 2016; the National Minimum Wage Acts 2000 and 2015; the Carer’s Leave Act 2001 (as amended); the Protection of Employees (Part-Time Work) Act 2001; the Protection of Employees (Fixed-Term Work) Act 2003; the Industrial Relations Acts, 1946 - 2015; the Data Protection Acts 1988 - 2018; the Workplace Relations Act 2015; the Employment (Miscellaneous Provisions) Act 2018, and the Safety Health and Welfare at Work Act 2005-2014) or pursuant to contract, in tort (including personal injury claims) or otherwise, howsoever arising.
I acknowledge that I have read, advised of and been given an opportunity to take legal advice on the Compromise Agreement and the provisions hereof and that I understand, accept and agree to the contents of the same and, furthermore, that I am signing this Waiver voluntarily without coercion of any description and with full understanding that I am releasing and compromising any and all claims and demands of every nature whatsoever that I have or might have against the Company and its Associated Undertakings and the other persons referred to above, save only in respect of the obligations of the Company as set out in the Compromise Agreement.
	
						
	Dated this 6 day of JAN [month] 2020 [year]
	 
	 

	 
	 
	 
	 
	 
	 

	Signed by:
	  /s/ Paul Treacy
	 
	Witness:
	  /s/ Veronique O’Sullivan
	 

	PAUL TREACYExhibit

Exhibit 10.27
[Jazz Pharmaceuticals Letterhead]
PERSONAL, PRIVATE AND CONFIDENTIAL
Mr. Finbar Larkin
[Address]
Terms and Conditions of Employment
Dear Finbar,
On behalf of Jazz Pharmaceuticals Ireland Limited of 4th Floor, Connaught House, 1 Burlington Road, Dublin 4, registered at the Companies Registration Office with company number 429847 (the “Company”), I am very pleased to offer you employment with the Company.
Your employment will be subject to the following terms and conditions.
		
	1.
	POSITION

Your position with the Company will be as Executive Director, Technical Operations or such other role as the Company considers appropriate.
		
	2.
	COMMENCEMENT DATE

Your employment will be deemed to have commenced on 9th April 2013 or an earlier date as advised and the terms and conditions set out in this contract will take effect from such date. No employment with a previous employer counts towards your period of continuous service with the Company.
You shall not work for anyone else while you are employed by the Company.
		
	3.
	PLACE OF WORK

You will be normally based at the Company’s offices at 4th Floor, Connaught House, 1 Burlington Road, Dublin 4 but will be required to travel within Ireland and abroad in carrying out your responsibilities.
You will be required to travel to the United States of America and other locations from time to time. Where you are required to work outside Ireland for a period of at least one month, prior to departure, you will be provided with written terms and conditions which will apply for the period spent abroad.
		
	4.
	HOURS OF WORK

You will determine your own hours of work and will be required to work the requisite hours and days in order to best perform your duties and to this end a degree of flexibility will be required on your part. You shall work a minimum of 37.5 hours per week from 9:00 am to 5:30 pm Monday to Friday, with a break of one hour for lunch each day. No 

extra remuneration will be paid for additional hours worked or where work is required to be performed on a weekend.
		
	5.
	REPORTING STRUCTURE

You will report directly to the Vice President, Product Development, Michael Desjardin. However the reporting structure may change from time to time, at the discretion of the Chief Financial Officer, the Chief Executive Officer or the Board of Directors (the “Board”).
		
	6.
	SALARY

		
	6.1.
	Your initial salary will be €170,000 per annum and shall accrue from day to day. This will be paid to you monthly in arrears on the last day of each month by credit transfer directly to your bank account. Your salary will be subject to annual review each year on the anniversary of the date of this contract. There is no obligation to award an increase. There will be no review of the salary after notice has been given by either party to terminate your employment.

		
	6.2.
	All payments to you will be subject to deductions of tax, PRSI, Universal Social Charge and any other deductions required by law or provided for in this contract. You will be notified each month by the Company of the amount of your gross and net remuneration and of the nature and amount of all deductions.

		
	6.3.
	For the purposes of the National Minimum Wage Act, 2000, the pay reference period shall be a month. In accordance with section 23 of the Act, you may request from the Company a written statement of your average hourly rate of pay for any pay reference period (other than a current pay reference period) falling within the twelve month period immediately preceding the request.

		
	6.4.
	The Company may deduct from your salary, or other sums owed to you, any money owed to the Company by you. Where the Company suffers loss as a result of your actions or omissions, deductions will be made only after you have received written notification providing at least one full week’s notice that the deduction will be made. The deduction must take place within 6 months of the loss/cost originally being incurred.

		
	7.
	BONUS

		
	7.1.
	You may be entitled to be considered for a bonus based on your performance. Any bonus payment will be made entirely at the sole discretion of the Board, at such intervals and subject to such conditions as the Board may in its absolute discretion determine from time to time.

		
	7.2.
	Any bonus payment to you shall be purely discretionary and shall not form part of your contractual remuneration under this contract. If the Company makes a payment to you, it shall not be obliged to make subsequent bonus payments.

		
	7.3.
	You will not be entitled to a bonus if your employment has been terminated, or notice of such termination has been given by either you or the Company, prior to the date the bonus is paid.

		
	8.
	EQUITY

Subject to approval by the Board of Director, your offer includes a grant of options to purchase 3,150 Jazz Pharmaceuticals ordinary shares and a grant of 1,575 restricted stock units (RSUs) giving you a right to receive Jazz Pharmaceuticals ordinary shares at a future date. Subject to the plan as in effect and your continued employment on each vesting date as per the Company equity plan.
		
	9.
	EXPENSES

All properly vouched and authorised expenses incurred by you on Company business will be reimbursed by the Company.
		
	10.
	HOLIDAYS

		
	10.1.
	You will be entitled to 21 days’ holidays (exclusive of all Irish bank and other public holidays in accordance with the Organisation of Working Time Act 1997) in each year. Your holidays are to be taken by arrangement with the Company, at such time or times that the Company considers to be most convenient having regard to the requirements of your position.

		
	10.2.
	The Company’s holiday year runs from 1 January to 31 December. Holidays from the previous year may not be carried over to the following year except with the Company's consent. Upon notice of termination of employment being served by either party, the Company may, subject to the provisions of the Organisation of Working Time Act 1997, require you to take any unused holidays accrued at that time during any notice period. Alternatively, the Company may, at its discretion, on termination of the employment, make a payment in lieu of accrued contractual holiday entitlement.

		
	10.3.
	If you are ill during a period of annual leave and have a valid medical certificate for the days that you were ill, these sick days will not be counted as annual leave days.

		
	10.4.
	If on termination of employment, you have taken in excess of your accrued holiday entitlement, the Company shall be entitled to recover from you by way of deduction from any payments due to you or otherwise, one day’s pay for each excess day (calculated at l/260th of your salary for each excess day).

		
	11.
	PENSION

At this time, the Company has no pension scheme. The Company does provide access to a personal retirement savings account (PRSA). If you wish to begin making contributions to a PRSA, please contact Bridget O’Brien. If and when the Company installs a pension scheme, you will be eligible to participate in accordance with the plan.
		
	12.
	DUTIES

You will carry out duties as assigned to you from time to time by the Company. Your area of work and/or specific responsibilities may be altered from time to time by the Company as the circumstances of the business dictate.

		
	13.
	PERIOD OF EMPLOYMENT

Subject to the provisions of Clauses 15, 16 and 22, your employment will continue until terminated by you or the Company giving the other at least 8 weeks’ written notice of termination (or, if longer, the period required by law).
		
	14.
	PAYMENT IN LIEU OF NOTICE / GARDEN LEAVE

Where notice of termination of your employment is given, whether by you or the Company, the Company will have the right to:
		
	14.1.
	pay you in lieu of notice the amount of your entitlement to salary in respect of such notice period; or

		
	14.2.
	require you to cease performing or exercising during some or all of the remainder of any notice period some or all of the powers, authorities and discretions delegated to you in your employment and/or to cease attending your place of work during such period.

		
	15.
	TERMINATION WITHOUT NOTICE

Your employment may be terminated without prior notice if, at any time after the date of this contract, you:
		
	15.1.
	are guilty of any material breach or non-observance of the provisions contained in this contract;

		
	15.2.
	are guilty of any serious or gross misconduct and/or negligence in the discharge of the duties of your employment or in connection with or affecting the business of the Company;

		
	15.3.
	commit any serious act of dishonesty or repeated acts of dishonesty;

		
	15.4.
	cease to be eligible to work in the Republic of Ireland; or

		
	15.5.
	are convicted of a criminal offence which the Company considers affects or could affect your position within the Company (other than minor traffic offences).

		
	16.
	NORMAL RETIREMENT AGE

The Company’s normal retirement age is 65. Your employment will end automatically on your 65th birthday if it has not terminated before then in accordance with the provisions of this contract.
		
	17.
	ILLNESS

		
	17.1.
	Absences from work for whatever reason must be notified to your Manager as soon as possible before your usual start time on the first day of absence. You should telephone your Manager and confirm the reason for your absence and the expected length of such 

absence. Text messaging and emails are unacceptable means of communication for this purpose.
		
	17.2.
	Payment of salary for any absences attributable to illness will be entirely at the sole discretion of the Company.

		
	17.3.
	If you are at any time prevented by illness, injury, accident or any other circumstances from discharging all your duties for a period of three consecutive days, then a satisfactory certificate will be required from your doctor in respect of such absence.

		
	17.4.
	The Company reserves the right, at any time, to require you to undergo a medical examination by a Doctor or Consultant nominated by the Company, in which event you agree to consent to this request and the Company will bear the cost of such examination.

		
	17.5.
	If your absence is or appears to be occasioned by actionable negligence, nuisance or breach of any statutory duty on the part of a third party in respect of which damages are or may be recoverable, you shall immediately notify your Manager of that fact and of any claim, compromise, settlement or judgment made or awarded in connection with it and all relevant particulars that the Company may reasonably require. You shall, if you have been in receipt of salary for a period of absence and if required by the Company, refund to the Company that part of any damages or compensation recovered by you relating to the loss of earnings for the period of sickness as the Company may reasonably determine less any costs borne by you in connection with the recovery of such damages or compensation, provided that the amount to be refunded shall not exceed the total amount paid to you by the Company in respect of the period of sickness.

		
	18.
	DISCIPLINARY RULES AND PROCEDURE

		
	18.1.
	You will conduct yourself with propriety at all times and with due regard for the Company and each of its associated companies and the clients and employees of each such company.

		
	18.2.
	In the event that your conduct or performance falls short of the standards required by the Company or the Board in any respect, (other than cases of misconduct) you will receive at first instance, a verbal warning, followed, if necessary in the event of a repetition, by a written warning which, in appropriate circumstances, may be deemed to be a final written warning. In the event of further breach of conduct or poor performance, and following due investigation during which you will be afforded an opportunity to make whatever representations you consider appropriate, your employment may be terminated by the Company, with or without notice as is deemed appropriate. Where appropriate, because of the gravity of your conduct or performance, the Company reserves the right to commence this procedure at any stage

		
	18.3.
	In order to investigate a complaint against you, the Company may suspend you on full pay for as long as may be necessary to carry out an investigation and hold a disciplinary hearing.

		
	19.
	MONITORING

		
	19.1.
	You consent to the Company monitoring and recording any use that you make of the Company’s electronic communications systems for the purpose of ensuring that the Company’s rules are being complied with and for legitimate business purposes. You shall comply with any electronic communication systems policies that the Company may issue from time to time.

		
	20.
	CONFIDENTIALITY

		
	20.1.
	You will not, except as authorised or required by your duties, reveal to any person, persons or company any information of a confidential or proprietary nature, including any trade secrets, secret or confidential operations, processes or dealings or any information concerning the organisation, business, finances, transactions or affairs of the Company, its subsidiary or associated companies or their existing or potential customers including but not limited to: client lists, prices, financial information, information on the marketing and development of products, which may come to your knowledge during the period of your employment with the Company (“Confidential Information”).  You will keep all Confidential Information entrusted to you completely secret and will not use or attempt to use any Confidential Information in any manner which may injure or cause loss either directly or indirectly to the Company or any of its subsidiary or associated companies or their existing or potential customers or its or their business or businesses.  This restriction will continue to apply after the termination of your employment without limit in point of time but will cease to apply to information or knowledge which may reasonably be said to have come into the public domain other than by reason of breach of the provisions of this contract.

		
	20.2.
	You will not during the term of your employment with the Company make, otherwise than for the benefit of the Company, any notes or memoranda relating to any matter within the scope of the business of the Company, its subsidiary or associated companies or their existing or potential customers or concerning any of the dealings or affairs of any such company nor will you either during the term of your employment with the Company or afterwards use or permit to be used any such notes or memoranda otherwise than for the benefit of the Company, it being the intention of the parties that all such notes or memoranda made by you will be the property of the Company and left at its offices upon the termination of your employment with the Company.

		
	21.
	PROPRIETARY RIGHTS

		
	21.1.
	In this Clause 21, “IP” means all intellectual property rights of whatever nature, including copyright (present and future), moral rights, patents, trademarks, trade names, domain names, rights in get-up, goodwill and the right to sue for passing off or unfair competition, rights in computer software, design rights, rights to inventions and database rights (whether or not any of these is registered and including any applications for registration of any such rights), rights to preserve the confidentiality of information(including trade secrets and know-how) and any other intellectual property rights, in each case whether registered or unregistered and including all applications (or rights to apply) for and be granted, renewals or extensions of, and rights to claim priority 

from, such rights and all similar or equivalent rights or forms of protection which may now or in the future subsist in any part of the world.
		
	21.2.
	You will immediately disclose to the Company in writing full details of any discovery, invention, process or improvement in procedure made or discovered by you (whether or not in conjunction with any other person or persons) together with all works embodying IP rights while in the employment of the Company in connection with or in any way affecting or relating to the business of the Company, its subsidiary or associated companies or capable of being used or adapted for use therein or in connection therewith (“Inventions”). You acknowledge that all IP rights subsisting (or which may in the future subsist) in all such Inventions and works shall automatically, on creation, vest in the Company absolutely. To the extent that they do not vest automatically, you hold them on trust for the Company. You agree promptly to execute all documents and do all acts as may, in the opinion of the Company, be necessary to give effect to this clause.

		
	21.3.
	If and whenever required so to do (whether during or after the termination of your employment), you will without charge and at the expense of the Company or its nominee apply or join in applying for letters, patents or other forms of protection for any IP referred to in this Clause 20 and execute all instruments and do all things considered necessary in the absolute discretion of the Company in relation to the said IP including vesting all rights and titles to such IP, when obtained, in the Company (or its nominee) as sole beneficial owner, or in such other person as the Company may require.

		
	21.4.
	You irrevocably appoint the Company to be your attorney in your name and on your behalf to execute and do any such instruments or things and generally to use your name for the purpose of giving to the Company (or its nominee) the full benefit of the provisions of this Clause 21. A certificate in writing signed by any executive or the Secretary of the Company that any instrument or act falls within the authority conferred in this Clause 21.4 will be conclusive evidence that such is the case in favour of a third party.

		
	22.
	RESTRICTIVE COVENANTS

		
	22.1.
	You may not during the period of your employment with the Company, without prior written consent of the Company, engage, whether directly or indirectly, in any business or employment which is similar to or competitive with the business of the Company or its subsidiary or associated companies or which may in the Company’s opinion impair your ability to act at all times in the best interest of the Company.

		
	22.2.
	In order to protect the Confidential Information and business connections of the Company to which you have access as a result of your employment, you covenant with the Company that you shall not:

		
	22.2.1.
	for 6 months after the date of the termination of your employment, in the Republic of Ireland be employed, engaged, concerned or interested, in any business directly competing with the products sold by the Company or its subsidiary or associated companies at that time.

		
	22.2.2.
	for a period of 6 months after the termination of your employment, offer to employ or otherwise entice away from the Company or its subsidiary or associated companies, any 

person who was at any time in the twelve months prior to the termination of your employment with the Company employed or engaged by the Company or its subsidiary or associated companies.
		
	22.2.3.
	for a period of 6 months after the termination of your employment, solicit or endeavour to entice away from the Company or its subsidiary or associated companies the business or custom of any firm, company or person who, during the 12 months before your termination of employment was a customer or prospective customer of the Company or its subsidiary or associated companies about whom you became aware or informed in the course of your employment, with a view to providing goods or services to that firm, company or person in competition with the services provided by the Company.

		
	22.2.4.
	for a period of 6 months after the termination of your employment, be involved with the provision of goods or services to (or otherwise have any business dealings with) any firm, company or person who, during the 12 months before the termination of your employment, was in the habit of dealing with the Company or its subsidiary or associated companies, in the course of any business concern which is in competition with the business of the Company.

		
	22.2.5.
	at any time after the termination of your employment, represent yourself as connected with the Company as agent, consultant, director, employee, owner, partner, shareholder or in any other capacity.

		
	22.3.
	You acknowledge and agree that all of the restrictions contained in this contract are reasonable and necessary to protect the interests of the Company and its subsidiary and associated companies and you agree that the Company may seek equitable remedies to enforce them in addition to any other legal remedies it has.

		
	22.4.
	The restrictions above apply to you acting directly or indirectly and on your own behalf or on behalf of, or in conjunction with, any firm, company or person.

		
	22.5.
	The time periods for which the restrictions apply shall be reduced by any period that you spend on garden leave.

		
	22.6.
	If any provision in this Clause 22 is deemed to be, or becomes invalid, illegal, void or unenforceable under applicable laws, such provision will be deemed amended to conform to applicable laws so as to be valid and enforceable (including, by way of example, by restricting the area, duration and/or scope of the covenants in to such area, duration and/or scope as would be held reasonable), or if it cannot be so amended without materially altering the intention of the parties, it will be deleted, but the validity, legality and enforceability of the remaining provisions of this contract shall not be impaired or affected in any way.

		
	23.
	PROBATIONARY PERIOD

		
	22.1
	The first six months of your employment will be on a probationary basis. The Company may, at its discretion, extend the probationary period for a further period of up to four months where it deems appropriate. During the probationary period your performance and suitability will be monitored and your employment is subject to the satisfactory completion of the probationary period. Your employment may be terminated at any time 

during the probationary period on the giving of two weeks’ notice by you or by the Company. The Company reserves the right to make a payment in lieu of notice.
		
	24.
	DATA PROTECTION ACTS 1988 AND 2003

		
	24.1.
	You hereby acknowledge that during the course of your employment with the Company, the Company will keep personal data and sensitive personal data (e.g. doctor’s certificates or medical reports) relating to you on computer and in manual files/paper files. You hereby acknowledge and agree that the Company is permitted to hold and process personal information about you as part of its personnel and other business records and may use such information in the course of the Company’s business. You further agree that the Company may disclose such information to third parties in the event that such disclosure is in the Company’s view required by the proper conduct of the Company’s business.  This clause applies to information held, used or disclosed in any medium.

		
	25.
	HEALTH & SAFETY

		
	25.1.
	The Company takes seriously its obligations regarding the safety, health and welfare of its employees and in that regard your attention is drawn to the Company safety statement (which is available for viewing on the intranet). By signing this contract, you agree to take reasonable care of your own safety and health and that of any other persons who may be affected by your acts or admissions while at work. You also agree to cooperate with the Company and any other person to enable compliance with any provision of the Safety, Health and Welfare at Work Acts 1989 and 2005 and any Regulation made thereunder.

		
	26.
	COLLECTIVE AGREEMENT

		
	26.1.
	There is no collective agreement which directly affects your employment.

		
	27.
	MISCELLANEOUS PROVISIONS

		
	27.1.
	Notices. Any notice under this contract will be given in writing and will be deemed to have been duly given if delivered personally to the addressee or the duly authorised agent of the addressee or sent by prepaid registered post to the last known address of the party to whom such notice is given. Any such notice will be deemed to have been duly given at the time of delivery if delivered personally, or two working days after posting if sent by prepaid registered post.

		
	27.2.
	Entire Agreement. This contract is in substitution for all previous agreements and undertakings (if any) either written or verbal between the Company and you, and all such agreements and undertakings will be deemed to have been terminated by mutual consent as from the date of your execution of this contract.

		
	27.3.
	Governing Law and Jurisdiction. This Agreement shall be governed by and construed in accordance with the laws of Ireland, and shall be subject to the exclusive jurisdiction of the Irish courts.

		
	27.4.
	The information contained in this contract constitutes a written statement of particulars of your employment with the Company in accordance with the requirements of section 3 of the Terms of Employment Act 1994 and 2001.

***
If you choose to accept the terms and conditions of employment set out in this contract, please sign the enclosed copy of the contract and return it to me.

	
			
	Yours sincerely

/s/ Fintan Keegan
	 

	Fintan Keegan
Duly authorised for and on behalf of
Jazz Pharmaceuticals Ireland Limited

	 

	 
	I accept employment with the Company on the terms and conditions as set out in the Company’s contract of which this is a copy.

	 
	Signed:
	/s/ Finbar Larkin

	 
	Dated:
	22 Feb 2013

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00305-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00305-of-00352.parquet"}]]